In vitro antimicrobial susceptibility of Listeria monocytogenes isolated in the UK and other Listeria species

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
A P MacGowanD S Reeves

Abstract

The MICs and MBCs of 21 antimicrobial agents were determined for 103 strains of Listeria monocytogenes isolated in the UK and 27 strains of other Listeria species. Ampicillin, penicillin, azlocillin, imipenem, gentamicin, netilmicin, amikacin, erythromycin, rifampicin, trimethoprim, clindamycin and vancomycin had good activity, while cephalothin, chloramphenicol, ciprofloxacin and ofloxacin were less active, and cefuroxime, enoxacin, norfloxacin and fosfomycin were the least active. Tetracycline had good activity against many strains, but the MIC was high for some. Unlike the other Listeria species tested, Listeria ivanovii was susceptible to fosfomycin. Inoculum size and media employed were shown to affect the MBC, tryptose phosphate broth yielding higher MBCs than Mueller-Hinton or Isosensitest broths.

References

Feb 26, 1977·Lancet·L D SabathB J Wilkinson
May 1, 1978·Antimicrobial Agents and Chemotherapy·G L WigginsJ C Feeley
Dec 1, 1987·European Journal of Clinical Microbiology·K V Rolston, G P Bodey
Jul 1, 1985·Antimicrobial Agents and Chemotherapy·S LarssonT Moestrup
Feb 1, 1983·Antimicrobial Agents and Chemotherapy·J S VenglarcikL M Dunkle

❮ Previous
Next ❯

Citations

Dec 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K HadornF H Kayser
Mar 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E M Jones, A P MacGowan
Oct 21, 1994·Biochimica Et Biophysica Acta·W NunomuraT Higashi
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew E FalagasPetros I Rafailidis
Aug 6, 2013·Foodborne Pathogens and Disease·Joana BarbosaPaula Teixeira
Apr 14, 2010·Antimicrobial Agents and Chemotherapy·A MorvanA Le Monnier
Feb 1, 1992·Antimicrobial Agents and Chemotherapy·C Poyart-SalmeronP Courvalin
Mar 1, 1994·Antimicrobial Agents and Chemotherapy·C MicheletP Berche
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·M Maurin, D Raoult
Jan 11, 2007·Letters in Applied Microbiology·Q LiC M Logue
Feb 28, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E. John ThrelfallJames McLauchlin
Nov 16, 2018·Journal of Medical Microbiology·Mina AghamaliEbrahim Kouhsari
Nov 1, 2007·Journal of Food Protection·Ana Isabel VitasIsabel García-Jalón
Apr 1, 1997·Clinical Microbiology Reviews·H HofM Kretschmar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.